As shown in Fig. 3A-C, experiments using in vivo xenografts revealed that breast cancer cells overexpressing TSP50 had a considerably greater tumor-forming efficiency and a significantly larger tumor volume and weight than control cells. Here, PRSS50 is linked to breast carcinoma.